211 related articles for article (PubMed ID: 25096720)
1. PEGylated galactosylated cationic liposomes for hepatocytic gene delivery.
Naicker K; Ariatti M; Singh M
Colloids Surf B Biointerfaces; 2014 Oct; 122():482-490. PubMed ID: 25096720
[TBL] [Abstract][Full Text] [Related]
2. Glycosylated liposomes with proton sponge capacity: novel hepatocyte- specific gene carriers.
Habib S; Singh M; Ariatti M
Curr Drug Deliv; 2013 Dec; 10(6):685-95. PubMed ID: 23859358
[TBL] [Abstract][Full Text] [Related]
3. PEGylation potentiates hepatoma cell targeted liposome-mediated in vitro gene delivery via the asialoglycoprotein receptor.
Mkhwanazi NK; de Koning CB; van Otterlo WAL; Ariatti M; Singh M
Z Naturforsch C J Biosci; 2017 Jul; 72(7-8):293-301. PubMed ID: 28063265
[TBL] [Abstract][Full Text] [Related]
4. Novel serum-tolerant lipoplexes target the folate receptor efficiently.
Gorle S; Ariatti M; Singh M
Eur J Pharm Sci; 2014 Aug; 59():83-93. PubMed ID: 24769039
[TBL] [Abstract][Full Text] [Related]
5. Biotin-directed assembly of targeted modular lipoplexes and their transfection of human hepatoma cells in vitro.
Singh A; Ariatti M; Singh M; Hawtrey A; Naidoo R
Drug Deliv; 2010 Aug; 17(6):426-33. PubMed ID: 20469969
[TBL] [Abstract][Full Text] [Related]
6. Novel neo glycolipid: formulation into pegylated cationic liposomes and targeting of DNA lipoplexes to the hepatocyte-derived cell line HepG2.
Narainpersad N; Singh M; Ariatti M
Nucleosides Nucleotides Nucleic Acids; 2012; 31(3):206-23. PubMed ID: 22356236
[TBL] [Abstract][Full Text] [Related]
7. Novel targeted liposomes deliver sirna to hepatocellular carcinoma cells in vitro.
Dorasamy S; Narainpersad N; Singh M; Ariatti M
Chem Biol Drug Des; 2012 Nov; 80(5):647-56. PubMed ID: 22783887
[TBL] [Abstract][Full Text] [Related]
8. Cytofectin amine head group modification and degree of liposome pegylation: factors influencing gene transfer.
Daniels A; Noor-Mahomed N; Singh M; Ariatti M
Indian J Pharm Sci; 2011 Jul; 73(4):381-6. PubMed ID: 22707820
[TBL] [Abstract][Full Text] [Related]
9. Asialoglycoprotein receptor-mediated gene transfer using novel galactosylated cationic liposomes.
Kawakami S; Yamashita F; Nishikawa M; Takakura Y; Hashida M
Biochem Biophys Res Commun; 1998 Nov; 252(1):78-83. PubMed ID: 9813149
[TBL] [Abstract][Full Text] [Related]
10. Spacer Length: A Determining Factor in the Design of Galactosyl Ligands for Hepatoma Cell-Specific Liposomal Gene Delivery.
Mbatha L; Chakravorty S; de Koning CB; van Otterlo WA; Arbuthnot P; Ariatti M; Singh M
Curr Drug Deliv; 2016; 13(6):935-45. PubMed ID: 26906564
[TBL] [Abstract][Full Text] [Related]
11. Effect of Poly(ethylene glycol) Spacer on Peptide-Decorated Hepatocellular Carcinoma-Targeted Lipoplexes In Vitro.
Govender J; Singh M; Ariatti M
J Nanosci Nanotechnol; 2015 Jun; 15(6):4734-42. PubMed ID: 26369105
[TBL] [Abstract][Full Text] [Related]
12. Gene delivery with active targeting to ovarian cancer cells mediated by folate receptor alpha.
He Z; Yu Y; Zhang Y; Yan Y; Zheng Y; He J; Xie Y; He G; Wei Y; Song X
J Biomed Nanotechnol; 2013 May; 9(5):833-44. PubMed ID: 23802413
[TBL] [Abstract][Full Text] [Related]
13. Complexes containing cationic and anionic pH-sensitive liposomes: comparative study of factors influencing plasmid DNA gene delivery to tumors.
Chen Y; Sun J; Lu Y; Tao C; Huang J; Zhang H; Yu Y; Zou H; Gao J; Zhong Y
Int J Nanomedicine; 2013; 8():1573-93. PubMed ID: 23637529
[TBL] [Abstract][Full Text] [Related]
14. Physicochemical Factors That Influence the Biocompatibility of Cationic Liposomes and Their Ability to Deliver DNA to the Nuclei of Ovarian Cancer SK-OV-3 Cells.
Sun M; Yuan Y; Lu F; Di Pasqua AJ
Materials (Basel); 2021 Jan; 14(2):. PubMed ID: 33466992
[TBL] [Abstract][Full Text] [Related]
15. A novel cationic cholesterol derivative, its formulation into liposomes, and the efficient transfection of the transformed human cell lines HepG2 and HeLa.
Kisoon N; Ariatti M; Moodley T
Drug Deliv; 2002; 9(3):161-7. PubMed ID: 12396733
[TBL] [Abstract][Full Text] [Related]
16. Stealth lipoplex decorated with triazole-tethered galactosyl moieties: a strong hepatotropic gene vector.
Govender D; Islam RU; De Koning CB; van Otterlo WA; Arbuthnot P; Ariatti M; Singh M
Biotechnol Lett; 2015 Mar; 37(3):567-75. PubMed ID: 25432417
[TBL] [Abstract][Full Text] [Related]
17. PEGylated and non-PEGylated siRNA lipoplexes formulated with cholesteryl cytofectins promote efficient luciferase knockdown in HeLa tat luc cells.
Daniels A; Singh M; Ariatti M
Nucleosides Nucleotides Nucleic Acids; 2013; 32(4):206-20. PubMed ID: 24001194
[TBL] [Abstract][Full Text] [Related]
18. Post-pegylated lipoplexes are promising vehicles for gene delivery in RPE cells.
Peeters L; Sanders NN; Jones A; Demeester J; De Smedt SC
J Control Release; 2007 Aug; 121(3):208-17. PubMed ID: 17630013
[TBL] [Abstract][Full Text] [Related]
19. In vivo gene delivery to the liver using novel galactosylated cationic liposomes.
Kawakami S; Fumoto S; Nishikawa M; Yamashita F; Hashida M
Pharm Res; 2000 Mar; 17(3):306-13. PubMed ID: 10801219
[TBL] [Abstract][Full Text] [Related]
20. DODAB:monoolein-based lipoplexes as non-viral vectors for transfection of mammalian cells.
Silva JP; Oliveira AC; Casal MP; Gomes AC; Coutinho PJ; Coutinho OP; Oliveira ME
Biochim Biophys Acta; 2011 Oct; 1808(10):2440-9. PubMed ID: 21787746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
